RSPH - How New Treatments And U.S. Policy Changes Are Driving Healthcare Stocks
2025-09-12 11:30:00 ET
Pharma and biotech stocks have struggled lately as uncertainty over the potential impact of tariffs and pricing pressures. Jasper Hellweg, Security Analyst with Argus Research, joins MoneyTalk to discuss how new treatment types and U.S. policy changes could be catalysts for the healthcare sector....
How New Treatments And U.S. Policy Changes Are Driving Healthcare Stocks